Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-11
2010-02-02
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S356000
Reexamination Certificate
active
07655659
ABSTRACT:
Compositions and methods are provided for reversing and/or inhibiting inflammation, e.g., by inhibiting prostaglandin and/or COX-2 production, using one or more indolequinazoline alkaloids, preferably in combination with butylated hydroxytoluene. The preferred indolequinazoline alkaloids are rutaecarpine, evodiamine, and dehydroevodiamine, which are naturally found in unpurified form in the traditional Chinese medicine Wu Chu Yu made from the fruit of the herb,Evodia rutaecarpa.
REFERENCES:
patent: 5592956 (1997-01-01), Ju et al.
patent: 5998421 (1999-12-01), Yokoo et al.
patent: 6214831 (2001-04-01), Yokoo et al.
patent: 6239114 (2001-05-01), Guthrie et al.
patent: 6323241 (2001-11-01), Yeager et al.
patent: 2007/0207195 (2007-09-01), Yarosh et al.
patent: 1568998 (2005-01-01), None
patent: 59-122414 (1984-07-01), None
patent: 60-224622 (1985-11-01), None
patent: 4-305527 (1992-10-01), None
patent: 11-246423 (1999-09-01), None
patent: 2001-0018658 (2001-03-01), None
Hu Chang-Ping, et al.; “Research progress in pharmacological actions of evodiamine and rutaecarpine;” Chinese Pharmacological Bulletin; 19(10): 1084-1087; 2003, (Eng. Abstract).
Bergman et al. Studies of Rutaecarpine and Related Quinazolinocarboline Alkaloids. J. Org. Chem. 50: 1246-1255, 1985.
Chavan et al. A Facile Total Synthesis of Rutaecarpine. Tetrahedron Letters. 45: 997-999, 2004.
Chiou et al. Comparative Study on the Vasodilatory Effects of Three Quinazoline Alkaloids Isolated fromEvodia rutaecarpa. J. Nat. Prod. 59: 374-378, 1996.
Coverly et al. Susceptibility to skin stinging, non-immunologic contact uticaria and acute skin irritation; is there a relationship? Contact Dermatitis 38:90-95, 1998.
Duteil et al. Objective assessment of topical corticosteroids and non-steroidal anti-inflammatory drugs in methyl-nicotinate-induced skin inflammation. Clin. Exp. Dermatol 15:195-199, 1990.
Gupta, S. The Role of Phytopharmaceuticals in Topical Pain Relief. HAPPI Dec. 2001, p. 110.
Issachar et al. Correlation between percutaneous penetration of methyl nicotinate and sensitive skin, using laser Doppler imaging. Contact Dermatitis 39:182-186, 1998.
Kobayashi et al. Capsaicin-Like Anti-Obese Activities of Evodiamine from Fruits ofEvodia rutaecarpa, a Vanilloid Receptor Agonist. Planta Med. 67: 628-633, 2001.
Kobayashi et al. The Positive Ionotropic and Chronotropic Effects of Evodiamine and Rutaecarpine, Indoloquinazoline Alkaloids Isolated from the Fruits ofEvodia rutaecarpa, on the Guinea-Pig Isolated Right Atria: Possible Involvement of Vanilloid Receptors. Planta Med. 67:244-248, 2001.
Kobayashi, Y. The Nociceptive and Anti-Nociceptive Effects of Evodiamine from fruits ofEvodia rutaecarpain Mice. Planta Med. 69:425-428, 2003.
Mahns, et al. Contribution of UVB and UVA to UV-dependent stimulation of cyclo-oxygenase-2 expression in artificial epidermis. Photochem. Photobiol. Sci. 3:257-262, 2004.
Matsuda et al. Antinociceptive Activities of 70% Methanol Extract of Evodia Frutus (Fruit ofEvodia rutaecarpavar. bodinieri) and Its Alkaloidal Components. Biol. Pharm. Bull. 20 (3) 243-248, 1997.
Matsuda, et al. Antinociceptive and anti-inflammatory activities of limonin isolated from the fruits ofEvodia rutaecarpavar. bodinieri. Planta Med. May; 64(4):339-42, 1998.
Moon, et al. A new class of COX-2 inhibitor, Rutaecarpine fromEvodia rutaecarpa. Inflamm. Res. 48: 621-625, 1999.
Morrow et al. Identification of skin as a major site of prostaglandin D2release following oral administration of niacin in humans. J. Invest. Dermatol. 98:812-815, 1992.
Sheu, J-R. Pharmacological Effect of Rutaecarpine, an Alkaloid Isolated fromEvodia rutaecarpa. Cardiovascular Drug Rev. 17:237-245, 1999.
Thuille et al. Bactericidal activity of herbal extracts. Int. J. Hyg. Environ. Health. 206: 217-221, 2003.
Ward et al. Niacin skin flush in schizophrenia: a preliminary report. Schizophrenia Res. 29:269-274.
Wilkin et al. Prostaglandins and nicotinate-provoked increase in cutaneous blood flow. Clin. Pharmacol. Ther. 38:273-277, 1985.
Woo et al. Rutaecarpine, a quinazolinocarboline alkaloid, inhibits prostaglandin production in raw264.7 macrophages. Planta Med . 67(6):505-509, 2001.
Brown David A.
Canning Matthew T.
Yarosh Daniel B.
Applied Genetics Incorporated Dermatics
Henley, III Raymond J
LandOfFree
Biomimetic of Evodia rutaecarpa fruit extract for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomimetic of Evodia rutaecarpa fruit extract for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomimetic of Evodia rutaecarpa fruit extract for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4176203